Group One Trading’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-393
Closed -$108K 8903
2025
Q4
$108K Buy
+393
New +$107K ﹤0.01% 4941
2025
Q2
Sell
-3,108
Closed -$664K 8746
2025
Q1
$696K Sell
3,108
-1,623
-34% -$447K ﹤0.01% 2783
2024
Q4
$1.55M Sell
4,731
-2,611
-36% -$822K ﹤0.01% 2144
2024
Q3
$2.2M Buy
7,342
+1,620
+28% +$496K 0.01% 1640
2024
Q2
$1.88M Buy
+5,722
New +$2.02M 0.01% 1497
2022
Q3
Sell
-20,500
Closed -$6.2M 8343
2022
Q2
$6.2M Buy
20,500
+12,900
+170% +$4.2M 0.01% 1144
2022
Q1
$3.12M Buy
+7,600
New +$2.98M ﹤0.01% 1951
2021
Q3
Sell
-300
Closed -$126K 8877
2021
Q2
$108K Sell
300
-100
-25% -$33K ﹤0.01% 5874
2021
Q1
$113K Buy
+400
New +$114K ﹤0.01% 5555
2020
Q1
Sell
-463
Closed -$70K 5806
2019
Q4
$70K Sell
463
-76
-14% -$11.1K ﹤0.01% 3852
2019
Q3
$76K Sell
539
-250
-32% -$34.4K ﹤0.01% 3744
2019
Q2
$99K Buy
+789
New +$93.1K ﹤0.01% 3356

Other funds holding WST

Group One Trading's WST Position: Q1 2026 in Review

Group One Trading sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 393 shares — an estimated $108K sold.

Group One Trading first reported a position in WST in Q2 2019 and held it in 12 quarters. The position peaked at $6.2M in Q2 2022. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Group One Trading reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 393 West Pharmaceutical shares in Q1 2026, an estimated $108K.
  • Group One Trading first reported a position in West Pharmaceutical in Q2 2019 and held it in 12 quarters.
  • Group One Trading's West Pharmaceutical position peaked at $6.2M in Q2 2022.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.